All news

Inovio soars 225% pre-market on FDA accelerated approval and $80.4 million court award

Investing.com · · AI-summarised by FinFlash

Inovio Pharmaceuticals jumped 225.4% in pre-open trading to

So What?

Approval transforms Inovio into a commercial-stage company and pressures rival Precigen. Watch launch pricing, payer coverage and any equity raise after the surge.

Read original source

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.